Ms. Hui Ma is a Partner at King & Wood Mallesons (KWM) specializing in intellectual property (IP) law. With over 18 years of experience, she focuses on patent litigation, patent lifecycle management, and support transactions within the healthcare and advanced materials industries. Ma Hui combines her technical expertise in biochemistry and engineering to provide effective legal solutions and manage significant patent disputes.

Ms. Ma advised in many patent validity cases relating to blockbuster drugs, including Sovaldi, Januvia, Xtandi, CRISPR technology, siRNA technology, Lokelma, etc. and has rich experience in providing IP validity and risk analysis in infringement cases with respect to the business perspective. Ms. Ma is also experienced in patent linkage and administrative enforcement cases, helping clients to protect their IP via effective and timely routes.